Pepstatin A, a pentapeptide with the molecular weight of 686, is a nat
urally occurring inhibitor of aspartyl proteases secreted by Streptomy
ces species. Above a critical concentration of 0.1 mM at low ionic str
ength and neutral pH, it can polymerize into filaments which may exten
d over several micrometers. After negative staining, these filaments s
how a helical substructure with characteristic diameters ranging from
6 to 12 nm. Selected images at higher magnification suggest the filame
nts are composed of two intertwined 6 nm strands. This is in agreement
with the optical diffraction analysis which additionally established
a periodic pitch of 25 nm for the helical intertwining. Rotary shadowi
ng of the pepstatin A filaments clearly demonstrated the right-handedn
ess of the helical twist. In physiological salt solution or at higher
concentrations of pepstatin A, a variety of higher order structures we
re observed, including ribbons, sheets and cylinders with both regular
and twisted or irregular geometries. Pepstatin A can interact with in
termediate filament subunit proteins. These proteins possess a long, a
lpha-helical rod domain that forms coiled-coil dimers, which through b
oth hydrophobic and ionic interactions form tetramers which, in turn:
in the presence of physiological salt concentrations, polymerize into
the 10 nm intermediate filaments. In the absence of salt, pepstatin A
and intermediate filament proteins polymerize into long filaments with
a rough surface and a diameter of 15-17 nm. This polymerization appea
rs to be primarily driven by nonionic interactions between pepstatin A
and polymerization-competent forms of intermediate filament proteins,
resulting in a composite filament. Polymerization-incompetent proteol
ytic fragments of vimentin, lacking portions of the head and/or tail d
omain, failed to copolymerize with pepstatin A into long filaments und
er these conditions. These peptides, as well as bovine serum albumin,
were found to stick to the surface of pepstatin A filaments, ribbons a
nd sheets. Independent evidence for direct association of pepstatin A
with intermediate filament subunit proteins was provided not only by e
lectron microscopy but also by UV difference spectra. Pepstatin A lose
s its ability to inhibit the aspartyl protease of the human immunodefi
ciency virus type 1 following polymerization into the higher order str
uctures described here. The amazing fact that pepstatin A can spontane
ously self-associate to form very large polymers seems to be a more ra
re event for such small peptides. The other examples of synthetic or n
aturally occurring oligopeptides discussed in this review which are ab
le to polymerize into higher order structures possess a common propert
y, their hydrophobicity, often manifested by clusters of valine or iso
leucine residues. The mechanism of homo- or heteropolymerization may b
e of interest not only for model studies on the polymerization of smal
l peptides, but also for practical development of soluble protease inh
ibitors and for the elucidation of the origin of the amyloid plaques o
f Alzheimer's disease and Down's syndrome, to name a few examples.